Showing results (351-360 of 475) with videos related to
Sort By:
Pageof 48
JHEP Reports : Innovation in Hepatology|August 14, 2025
Implementation of a care bundle improves PBC managementRachel Smith, Laura Burke, Nadir Abbas, et al.Hepatology (Baltimore, Md.)|October 13, 2017
A randomized trial of obeticholic acid monotherapy in patients with primary biliary cholangitisKris V Kowdley, Velimir Luketic, Roger Chapman, et al.Research Evaluation|May 9, 2014
Measuring the evolution and output of cross-disciplinary collaborations within the NCI Physical Sciences-Oncology Centers NetworkJodi E Basner, Katrina I Theisz, Unni S Jensen, et al.Journal of Hepatology|January 23, 2021
A randomized placebo-controlled trial of elafibranor in patients with primary biliary cholangitis and incomplete response to UDCAJörn M Schattenberg, Albert Pares, Kris V Kowdley, et al.Human Molecular Genetics|June 2, 2021
PAK1 inhibition reduces tumor size and extends the lifespan of mice in a genetically engineered mouse model of Neurofibromatosis Type 2 (NF2)Eric Hawley, Jeffrey Gehlhausen, Sofiia Karchugina, et al.Substance Use & Addiction Journal|July 10, 2026
Comparing Therapeutic Treatment Goals Across Settings for Those in or At-Risk for Substance Use Treatment in West AlabamaKelly Doudell, Erick Carranza, Jack Cassell, et al.Nature Communications|October 3, 2019
Framework engineering to produce dominant T cell receptors with enhanced antigen-specific functionSharyn Thomas, Fiyaz Mohammed, Rogier M Reijmers, et al.Nature Microbiology|May 19, 2025
The fast-evolving FIKK kinase family of Plasmodium falciparum can be inhibited by a single compoundHugo Belda, David Bradley, Evangelos Christodoulou, et al.Neuro-Oncology Advances|February 4, 2025
cIMPACT-NOW update 9: Recommendations on utilization of genome-wide DNA methylation profiling for central nervous system tumor diagnosticsKenneth Aldape, David Capper, Andreas von Deimling, et al.Alimentary Pharmacology & Therapeutics|September 22, 2025
Non-Response to Obeticholic Acid Is Associated With Heightened Risks of Developing Clinical Events in Primary Biliary CholangitisNadir Abbas, Rachel Smith, Ellina Lytvyak, et al.Pageof 48